How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Category: Injectibles
Injectibles
Popular
Injectibles
Latest
Galderma’s Relfydess Approved in China for Treatment of Frown Lines
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.
All
Latest
Shorter Radiation Course Safe for Breast Reconstruction Patients, Trial Finds
A clinical trial involving 828 patients found that three weeks of radiation following mastectomy did not increase reconstruction complications compared with the standard five-week course.
EU Approves Galderma’s Bone-Mimicking Injectable for Chin Augmentation
The hyaluronic acid gel is designed to mimic bone for lower face shaping and uses a new technology to provide firmness.
Read More
FDA Accepts Application for Botox to Treat Masseter Muscle Prominence
If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.
Read More
Hugel Aesthetics Expands US Support for Letybo With Direct Sales Force
The company is building a dedicated sales and medical affairs team to drive adoption of its neurotoxin and provide practices with direct clinical and commercial support.
Read More
Allergan Gets Approval for Short-Duration, Rapid-Onset Neurotoxin Boey in Europe
The treatment is the first short-duration facial injectable available in the region for the temporary improvement of lines between the eyebrows.
Read More
Evolus to Bring Profhilo to the United States Through New Partnership
The licensing and distribution agreement expands the company’s injectable portfolio into the skin quality category.
Read More
Allergan Wins First Approval for Short-Acting Neurotoxin in Canada
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.
Read More
FDA Clears New Injectable Option for Horizontal Neck Lines
Clinical trial results showed improvements in neck appearance lasting up to six months following treatment.
Read More
AAFPRS Notes Growing Patient Interest in Facelifts After Years of Filler
Facial plastic surgeons report growing patient interest in facelifts as more individuals reconsider long-term filler use and seek natural-looking facial rejuvenation.
Read More
Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
Read More
China Approves First Recombinant Botulinum Toxin for Glabellar Lines
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Read More
FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Toxin Application
Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
Read More
HA Fillers Report Highlights Gap Between Perception and Outcomes
Emily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.
Read More
Merz Aesthetics Receives EU Approval for New BELOTERO Balance Indications
Filler cleared for infraorbital hollow and horizontal forehead lines in Europe.
Read More
Hugel Signs Deal to Add ECM-based Skin Regeneration Injectable to Portfolio
Agreement for CellREDM highlights growing interest in regenerative injectables used alongside fillers.
Read More
Allergan Aesthetics Presents Data on Patient Demand for Natural-Looking Results
Allergan Aesthetics presented new research at AMWC 2026 indicating a shift toward subtle, natural-looking outcomes in hyaluronic acid injectables and emphasizing the role of personalized treatment approaches.
Read More